Skip to main content
Top
Published in: Aesthetic Plastic Surgery 1/2020

01-02-2020 | Injectable Filler | Original Article

PMMA Safety for Facial Filling: Review of Rates of Granuloma Occurrence and Treatment Methods

Author: Bruno Peres Paulucci

Published in: Aesthetic Plastic Surgery | Issue 1/2020

Login to get access

Abstract

PMMA is composed of microspheres suspended in bovine collagen. Once injected in a dermal area, the carrier is absorbed, giving place to collagen that gives volume and maintains the spheres in the place. This process may give origin to exacerbate foreign body reaction and granuloma. The frequency of such complication is not clear. The primary objective was to review and compare the frequencies of granuloma between the published studies. The secondary aim was to compare the therapies and efficacies. The series of cases in which PMMA was used as facial filler were reviewed, and the rate of granulomas was compared; the case report studies describing those complications were also reviewed, and the therapies and outcomes were quantified. The data showed general frequency of PMMA-related complications of 4.9% and granulomas 1.9%; the incidence of granuloma was 1/2075 patients-year, and the time to development ranged from 6 to 180 months. The most used therapies were steroid, surgery or both, with satisfactory results. In conclusion, considering the actual risks and benefits of PMMA, we may affirm that it is a safe filler; doctors and patients must be conscious of potential risks when deciding for its use.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
go back to reference Greco TM, Antunes MB, Yellin SA (2012) Injectable fillers for volume replacement in the aging face. Facial Plast Surg 28(1):8–20PubMed Greco TM, Antunes MB, Yellin SA (2012) Injectable fillers for volume replacement in the aging face. Facial Plast Surg 28(1):8–20PubMed
2.
go back to reference Cohen SR, Berner CF, Busso M, Gleason MC, Hamilton D, Holmes RE, Romano JJ, Rullan PP, Thaler MP, Ubogy Z, Vecchione TR (2006) ArteFill: a long-lasting injectable wrinkle filler material-summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg 118(3 Suppl):64S–76SPubMed Cohen SR, Berner CF, Busso M, Gleason MC, Hamilton D, Holmes RE, Romano JJ, Rullan PP, Thaler MP, Ubogy Z, Vecchione TR (2006) ArteFill: a long-lasting injectable wrinkle filler material-summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg 118(3 Suppl):64S–76SPubMed
3.
go back to reference Alcalay J, Alkalay R, Gat A, Yorav S (2003) Late-onset granulomatous reaction to Artecoll. Dermatol Surg 29(8):859–862PubMed Alcalay J, Alkalay R, Gat A, Yorav S (2003) Late-onset granulomatous reaction to Artecoll. Dermatol Surg 29(8):859–862PubMed
4.
go back to reference Cohen SR, Berner CF, Busso M, Clopton P, Hamilton D, Romano JJ, Rullan PP, Thaler MP, Ubogy Z, Vecchione TR (2007) Five-year safety and efficacy of a novel polymethylmethacrylate aesthetic soft tissue filler for the correction of nasolabial folds. Dermatol Surg 33(Suppl 2):S222–S230PubMed Cohen SR, Berner CF, Busso M, Clopton P, Hamilton D, Romano JJ, Rullan PP, Thaler MP, Ubogy Z, Vecchione TR (2007) Five-year safety and efficacy of a novel polymethylmethacrylate aesthetic soft tissue filler for the correction of nasolabial folds. Dermatol Surg 33(Suppl 2):S222–S230PubMed
5.
go back to reference Cohen S, Dover J, Monheit G, Narins R, Sadick N, Werschler WP, Karnik J, Smith SR (2015) Five-year safety and satisfaction study of PMMA-collagen in the correction of nasolabial folds. Dermatol Surg 41(Suppl 1):S302–S313PubMed Cohen S, Dover J, Monheit G, Narins R, Sadick N, Werschler WP, Karnik J, Smith SR (2015) Five-year safety and satisfaction study of PMMA-collagen in the correction of nasolabial folds. Dermatol Surg 41(Suppl 1):S302–S313PubMed
6.
go back to reference Salles AG, Lotierzo PH, Gemperli R, Besteiro JM, Ishida LC, Gimenez RP, Menezes J, Ferreira MC (2008) Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg 121(5):1811–1820PubMed Salles AG, Lotierzo PH, Gemperli R, Besteiro JM, Ishida LC, Gimenez RP, Menezes J, Ferreira MC (2008) Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg 121(5):1811–1820PubMed
7.
go back to reference Park TH, Seo SW, Kim JK, Chang CH (2012) Clinical experience with polymethylmethacrylate microsphere filler complications. Aesthet Plast Surg 36(2):421–426 Park TH, Seo SW, Kim JK, Chang CH (2012) Clinical experience with polymethylmethacrylate microsphere filler complications. Aesthet Plast Surg 36(2):421–426
8.
go back to reference Conejo-Mir JS, Sanz Guirado S, Angel Muñoz M (2006) Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg 32(8):1079–1081PubMed Conejo-Mir JS, Sanz Guirado S, Angel Muñoz M (2006) Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg 32(8):1079–1081PubMed
9.
go back to reference Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, Moschetti I, Phillips B, Thornton H (2011) Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document). Oxford Centre for Evidence-Based Medicine Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, Moschetti I, Phillips B, Thornton H (2011) Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document). Oxford Centre for Evidence-Based Medicine
10.
go back to reference Cohen SR, Holmes RE (2004) Artecoll: a long-lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 114(4):964–976PubMed Cohen SR, Holmes RE (2004) Artecoll: a long-lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 114(4):964–976PubMed
11.
go back to reference Bagal A, Dahiya R, Tsai V, Adamson PA (2007) Clinical experience with polymethylmethacrylate microspheres (Artecoll) for soft-tissue augmentation: a retrospective review. Arch Fac Plast Surg 9(4):275–280 Bagal A, Dahiya R, Tsai V, Adamson PA (2007) Clinical experience with polymethylmethacrylate microspheres (Artecoll) for soft-tissue augmentation: a retrospective review. Arch Fac Plast Surg 9(4):275–280
12.
go back to reference Solomon P, Sklar M, Zener R (2012) Facial soft tissue augmentation with Artecoll(®): a review of eight years of clinical experience in 153 patients. Can J Plast Surg 20(1):28–32PubMedPubMedCentral Solomon P, Sklar M, Zener R (2012) Facial soft tissue augmentation with Artecoll(®): a review of eight years of clinical experience in 153 patients. Can J Plast Surg 20(1):28–32PubMedPubMedCentral
13.
go back to reference Mani N, McLeod J, Sauder MB, Sauder DN, Bothwell MR (2013) Novel use of polymethyl methacrylate (PMMA) microspheres in the treatment of infraorbital rhytids. J Cosmet Dermatol 12(4):275–280PubMed Mani N, McLeod J, Sauder MB, Sauder DN, Bothwell MR (2013) Novel use of polymethyl methacrylate (PMMA) microspheres in the treatment of infraorbital rhytids. J Cosmet Dermatol 12(4):275–280PubMed
14.
go back to reference Lemperle G, Gauthier-Hazan N, Lemperle M (1998) PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthet Plast Surg 22(5):356–365 Lemperle G, Gauthier-Hazan N, Lemperle M (1998) PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthet Plast Surg 22(5):356–365
15.
go back to reference Carvalho Costa IM, Salaro CP, Costa MC (2009) Polymethylmethacrylate facial implant: a successful personal experience in Brazil for more than 9 years. Dermatol Surg 35(8):1221–1227PubMed Carvalho Costa IM, Salaro CP, Costa MC (2009) Polymethylmethacrylate facial implant: a successful personal experience in Brazil for more than 9 years. Dermatol Surg 35(8):1221–1227PubMed
16.
go back to reference Karnik J, Baumann L, Bruce S, Callender V, Cohen S, Grimes P, Joseph J, Shamban A, Spencer J, Tedaldi R, Werschler WP, Smith SR (2014) A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne scars. J Am Acad Dermatol 71(1):77–83PubMed Karnik J, Baumann L, Bruce S, Callender V, Cohen S, Grimes P, Joseph J, Shamban A, Spencer J, Tedaldi R, Werschler WP, Smith SR (2014) A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne scars. J Am Acad Dermatol 71(1):77–83PubMed
17.
go back to reference Mills DC, Camp S, Mosser S, Sayeg A, Hurwitz D, Ronel D (2013) Malar augmentation with a polymethylmethacrylate-enhanced filler: assessment of a 12-month open-label pilot study. Aesthet Surg J. 33(3):421–430PubMed Mills DC, Camp S, Mosser S, Sayeg A, Hurwitz D, Ronel D (2013) Malar augmentation with a polymethylmethacrylate-enhanced filler: assessment of a 12-month open-label pilot study. Aesthet Surg J. 33(3):421–430PubMed
18.
go back to reference Nácul AM (2005) Contour of the lower third of the face using an intramusculary injectable implant. Aesthet Plast Surg. 29(4):222–229 Nácul AM (2005) Contour of the lower third of the face using an intramusculary injectable implant. Aesthet Plast Surg. 29(4):222–229
19.
go back to reference Carle MV, Roe R, Novack R, Boyer DS (2014) Cosmetic facial fillers and severe vision loss. JAMA Ophthalmol 132(5):637–639PubMed Carle MV, Roe R, Novack R, Boyer DS (2014) Cosmetic facial fillers and severe vision loss. JAMA Ophthalmol 132(5):637–639PubMed
20.
go back to reference Castro AC, Collares MV, Portinho CP, Dias PC, Pinto R (2007) Extensive facial necrosis after infiltration of polymethylmethacrylate. Braz J Otorhinolaryngol 73(6):850 Castro AC, Collares MV, Portinho CP, Dias PC, Pinto R (2007) Extensive facial necrosis after infiltration of polymethylmethacrylate. Braz J Otorhinolaryngol 73(6):850
21.
go back to reference da Costa Miguel MC, Nonaka CF, dos Santos JN, Germano AR, de Souza LB (2009) Oral foreign body granuloma: unusual presentation of a rare adverse reaction to permanent injectable cosmetic filler. Int J Oral Maxillofac Surg 38(4):385–387PubMed da Costa Miguel MC, Nonaka CF, dos Santos JN, Germano AR, de Souza LB (2009) Oral foreign body granuloma: unusual presentation of a rare adverse reaction to permanent injectable cosmetic filler. Int J Oral Maxillofac Surg 38(4):385–387PubMed
22.
go back to reference Faria KM, Fonseca FP, Silva WG, Silva RN, Vargas PA, de Almeida OP, Lopes MA, Santos-Silva AR (2014) Fine needle aspiration cytology in the diagnosis of perioral adverse reactions to cosmetic dermal fillers. Oral Surg Oral Med Oral Pathol Oral Radiol 117(5):e393–e395PubMed Faria KM, Fonseca FP, Silva WG, Silva RN, Vargas PA, de Almeida OP, Lopes MA, Santos-Silva AR (2014) Fine needle aspiration cytology in the diagnosis of perioral adverse reactions to cosmetic dermal fillers. Oral Surg Oral Med Oral Pathol Oral Radiol 117(5):e393–e395PubMed
23.
go back to reference Friedmann DP, Kurian A, Fitzpatrick RE (2016) Delayed granulomatous reactions to facial cosmetic injections of polymethylmethacrylate microspheres and liquid injectable silicone: a case series. J Cosmet Laser Ther 18(3):170–173PubMed Friedmann DP, Kurian A, Fitzpatrick RE (2016) Delayed granulomatous reactions to facial cosmetic injections of polymethylmethacrylate microspheres and liquid injectable silicone: a case series. J Cosmet Laser Ther 18(3):170–173PubMed
24.
go back to reference Gelfer A, Carruthers A, Carruthers J, Jang F, Bernstein SC (2007) The natural history of polymethylmethacrylate microspheres granulomas. Dermatol Surg 33(5):614–620PubMed Gelfer A, Carruthers A, Carruthers J, Jang F, Bernstein SC (2007) The natural history of polymethylmethacrylate microspheres granulomas. Dermatol Surg 33(5):614–620PubMed
25.
go back to reference Hoffmann C, Schuller-Petrovic S, Soyer HP, Kerl H (1999) Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. J Am Acad Dermatol 40(1):100–102PubMed Hoffmann C, Schuller-Petrovic S, Soyer HP, Kerl H (1999) Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. J Am Acad Dermatol 40(1):100–102PubMed
26.
go back to reference Kadouch JA, Kadouch DJ, Fortuin S, van Rozelaar L, Karim RB, Hoekzema R (2013) Delayed-onset complications of facial soft tissue augmentation with permanent fillers in 85 patients. Dermatol Surg 39(10):1474–1485PubMed Kadouch JA, Kadouch DJ, Fortuin S, van Rozelaar L, Karim RB, Hoekzema R (2013) Delayed-onset complications of facial soft tissue augmentation with permanent fillers in 85 patients. Dermatol Surg 39(10):1474–1485PubMed
27.
go back to reference Limongi RM, Tao J, Borba A, Pereira F, Pimentel AR, Akaishi P, Velasco e Cruz AA (2016) Complications and Management of Polymethylmethacrylate (PMMA) injections to the midface. Aesthet Surg J. 36(2):132–135PubMed Limongi RM, Tao J, Borba A, Pereira F, Pimentel AR, Akaishi P, Velasco e Cruz AA (2016) Complications and Management of Polymethylmethacrylate (PMMA) injections to the midface. Aesthet Surg J. 36(2):132–135PubMed
28.
go back to reference Lombardi T, Samson J, Plantier F, Husson C, Küffer R (2004) Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 33(2):115–120PubMed Lombardi T, Samson J, Plantier F, Husson C, Küffer R (2004) Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 33(2):115–120PubMed
29.
go back to reference Quirino MR, Neves AC, Campos MS, Brandão AA, Anbinder AL (2012) Oral granuloma formation after injection of cosmetic filler. J Craniomaxillofac Surg 40(7):e194–e197PubMed Quirino MR, Neves AC, Campos MS, Brandão AA, Anbinder AL (2012) Oral granuloma formation after injection of cosmetic filler. J Craniomaxillofac Surg 40(7):e194–e197PubMed
30.
go back to reference Reisberger EM, Landthaler M, Wiest L, Schröder J, Stolz W (2003) Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol 139(1):17–20PubMed Reisberger EM, Landthaler M, Wiest L, Schröder J, Stolz W (2003) Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol 139(1):17–20PubMed
31.
go back to reference Rudolph CM, Soyer HP, Schuller-Petrovic S, Kerl H (1999) Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol 23(1):113–117PubMed Rudolph CM, Soyer HP, Schuller-Petrovic S, Kerl H (1999) Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol 23(1):113–117PubMed
32.
go back to reference Ledon JA, Savas JA, Yang S, Franca K, Camacho I, Nouri K (2013) Inflammatory nodules following soft tissue filler use: a review of causative agents, pathology and treatment options. Am J Clin Dermatol 14(5):401–411PubMed Ledon JA, Savas JA, Yang S, Franca K, Camacho I, Nouri K (2013) Inflammatory nodules following soft tissue filler use: a review of causative agents, pathology and treatment options. Am J Clin Dermatol 14(5):401–411PubMed
33.
go back to reference Silva MT, Curi AL (2004) Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr 62(3B):873–874PubMed Silva MT, Curi AL (2004) Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr 62(3B):873–874PubMed
34.
go back to reference Wolfram D, Tzankov A, Piza-Katzer H (2006) Surgery for foreign body reactions due to injectable fillers. Dermatology 213(4):300–304PubMed Wolfram D, Tzankov A, Piza-Katzer H (2006) Surgery for foreign body reactions due to injectable fillers. Dermatology 213(4):300–304PubMed
35.
go back to reference Wu W, Chayavichitsilp P, Hata T (2012) Extremely delayed granulomatous reaction to soft-tissue injectables (polymethyl methacrylate). J Am Acad Dermatol 67(5):e206–e207PubMed Wu W, Chayavichitsilp P, Hata T (2012) Extremely delayed granulomatous reaction to soft-tissue injectables (polymethyl methacrylate). J Am Acad Dermatol 67(5):e206–e207PubMed
36.
go back to reference Sidwell RU, McL Johnson N, Francis N, Bunker CB (2006) Cutaneous sarcoidal granulomas developing after Artecoll facial cosmetic filler in a patient with newly diagnosed systemic sarcoidosis. Clin Exp Dermatol 31(2):208–211PubMed Sidwell RU, McL Johnson N, Francis N, Bunker CB (2006) Cutaneous sarcoidal granulomas developing after Artecoll facial cosmetic filler in a patient with newly diagnosed systemic sarcoidosis. Clin Exp Dermatol 31(2):208–211PubMed
37.
go back to reference Fischer J, Metzler G, Schaller M (2007) Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. Arch Dermatol 143(4):507–510PubMed Fischer J, Metzler G, Schaller M (2007) Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. Arch Dermatol 143(4):507–510PubMed
38.
go back to reference Al-Qattan MM (2007) Late artecoll granulomas aggravated by pregnancy. Ann Plast Surg 58(5):592PubMed Al-Qattan MM (2007) Late artecoll granulomas aggravated by pregnancy. Ann Plast Surg 58(5):592PubMed
39.
go back to reference Bisschop C, Bruijn MS, Stenekes MW, Diercks GF, Hospers GA (2016) Foreign body reaction triggered by cytotoxic T lymphocyte-associated protein 4 blockade 25 years after dermal filler injection. Br J Dermatol 175(6):1351–1353PubMed Bisschop C, Bruijn MS, Stenekes MW, Diercks GF, Hospers GA (2016) Foreign body reaction triggered by cytotoxic T lymphocyte-associated protein 4 blockade 25 years after dermal filler injection. Br J Dermatol 175(6):1351–1353PubMed
40.
go back to reference Heath CR, David J, Taylor SC (2012) Sarcoidosis: are there differences in your skin of color patients? J Am Acad Dermatol 66(1):121.e1–121.e14 Heath CR, David J, Taylor SC (2012) Sarcoidosis: are there differences in your skin of color patients? J Am Acad Dermatol 66(1):121.e1–121.e14
41.
go back to reference Haneke E (2014) Adverse effects of fillers and their histopathology. Fac Plast Surg 30(6):599–614 Haneke E (2014) Adverse effects of fillers and their histopathology. Fac Plast Surg 30(6):599–614
43.
go back to reference Lemperle G, Morhenn V, Charrier U (2003) Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet Plast Surg 27(5):354–366 Lemperle G, Morhenn V, Charrier U (2003) Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet Plast Surg 27(5):354–366
44.
go back to reference Ahn CS, Rao BK (2014) The life cycles and biological end pathways of dermal fillers. J Cosmet Dermatol 13(3):212–223PubMed Ahn CS, Rao BK (2014) The life cycles and biological end pathways of dermal fillers. J Cosmet Dermatol 13(3):212–223PubMed
45.
go back to reference Fernandez-Cossio S, Castano-Oreja MT (2006) Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler. Plast Reconstr Surg 117:1789–1796PubMed Fernandez-Cossio S, Castano-Oreja MT (2006) Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler. Plast Reconstr Surg 117:1789–1796PubMed
46.
go back to reference Rosa SC, de Magalhães AV, de Macedo JL (2008) An experimental study of tissue reaction to polymethyl methacrylate (PMMA) microspheres (Artecoll) and dimethylsiloxane (DMS) in the mouse. Am J Dermatopathol 30(3):222–227PubMed Rosa SC, de Magalhães AV, de Macedo JL (2008) An experimental study of tissue reaction to polymethyl methacrylate (PMMA) microspheres (Artecoll) and dimethylsiloxane (DMS) in the mouse. Am J Dermatopathol 30(3):222–227PubMed
47.
go back to reference Vargas KF, Borghetti RL, Moure SP, Cherubini K, de Figueiredo MA (2016) Local and systemic tissue response submitted to injection of 2 and 30% polymethylmethacrylate in rats’ tongue. Gerodontology. 33(1):36–43PubMed Vargas KF, Borghetti RL, Moure SP, Cherubini K, de Figueiredo MA (2016) Local and systemic tissue response submitted to injection of 2 and 30% polymethylmethacrylate in rats’ tongue. Gerodontology. 33(1):36–43PubMed
48.
go back to reference de Melo Carpaneda E, Carpaneda CA (2012) Adverse results with PMMA fillers. Aesthet Plast Surg. 36(4):955–963 de Melo Carpaneda E, Carpaneda CA (2012) Adverse results with PMMA fillers. Aesthet Plast Surg. 36(4):955–963
49.
go back to reference Saylan Z (2003) Facial fillers and their complications. Aesthet Surg J. 23(3):221–224PubMed Saylan Z (2003) Facial fillers and their complications. Aesthet Surg J. 23(3):221–224PubMed
50.
go back to reference Signorini M, Liew S, Sundaram H, De Boulle KL, Goodman GJ, Monheit G, Wu Y, Trindade de Almeida AR, Swift A, Vieira Braz A, Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations (2016) Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg 137(6):961e–971ePubMed Signorini M, Liew S, Sundaram H, De Boulle KL, Goodman GJ, Monheit G, Wu Y, Trindade de Almeida AR, Swift A, Vieira Braz A, Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations (2016) Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg 137(6):961e–971ePubMed
51.
go back to reference Cotofana S, Schenck TL, Trevidic P, Sykes J, Massry GG, Liew S, Graivier M, Dayan S, de Maio M, Fitzgerald R, Andrews JT, Remington BK (2015) Midface: clinical anatomy and regional approaches with injectable fillers. Plast Reconstr Surg 136(5 Suppl):219S–234SPubMed Cotofana S, Schenck TL, Trevidic P, Sykes J, Massry GG, Liew S, Graivier M, Dayan S, de Maio M, Fitzgerald R, Andrews JT, Remington BK (2015) Midface: clinical anatomy and regional approaches with injectable fillers. Plast Reconstr Surg 136(5 Suppl):219S–234SPubMed
52.
go back to reference McCracken MS, Khan JA, Wulc AE, Holds JB, Fante RG, Migliori ME, Ebroon DA, Amato MM, Silkiss RZ, Patel BC (2006) Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthalmic Plast Reconstr Surg 22(3):188–191PubMed McCracken MS, Khan JA, Wulc AE, Holds JB, Fante RG, Migliori ME, Ebroon DA, Amato MM, Silkiss RZ, Patel BC (2006) Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthalmic Plast Reconstr Surg 22(3):188–191PubMed
53.
go back to reference Hatcher JL, Goldman ND (2014) Recognition and treatment of non-infectious hyaluronic acid reactions. J Dermatol Treat 25(6):513–515 Hatcher JL, Goldman ND (2014) Recognition and treatment of non-infectious hyaluronic acid reactions. J Dermatol Treat 25(6):513–515
54.
go back to reference Grunebaum LD, Bogdan Allemann I, Dayan S et al (2009) The risk of alar necrosis associated with dermal filler injection. Dermatol Surg 35:1635–1640PubMed Grunebaum LD, Bogdan Allemann I, Dayan S et al (2009) The risk of alar necrosis associated with dermal filler injection. Dermatol Surg 35:1635–1640PubMed
55.
go back to reference Adcock IM, Mumby S (2017) Glucocorticoids. Handb Exp Pharmacol 237:171–196PubMed Adcock IM, Mumby S (2017) Glucocorticoids. Handb Exp Pharmacol 237:171–196PubMed
56.
go back to reference Fischer HJ, Schweingruber N, Lühder F, Reichardt HM (2013) The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Mol Cell Endocrinol 380(1–2):99–107PubMed Fischer HJ, Schweingruber N, Lühder F, Reichardt HM (2013) The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Mol Cell Endocrinol 380(1–2):99–107PubMed
57.
go back to reference Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3(5):330–338PubMed Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3(5):330–338PubMed
58.
go back to reference Bijlard E, Steltenpool S, Niessen FB (2015) Intralesional 5-fluorouracil in keloid treatment: a systematic review. Acta Derm Venereol 95(7):778–782PubMed Bijlard E, Steltenpool S, Niessen FB (2015) Intralesional 5-fluorouracil in keloid treatment: a systematic review. Acta Derm Venereol 95(7):778–782PubMed
59.
go back to reference de Barros Silveira LK, de Oliveira FL, Alves Tde B, Rambaldi ML, de Andrade FC, Kelmer Sde C, Barbosa FC (2012) The therapeutic benefit of allopurinol in the treatment of foreign body granulomas caused by polymethylmethacrylate microspheres. Case Rep Dermatol Med 2012:945205PubMedPubMedCentral de Barros Silveira LK, de Oliveira FL, Alves Tde B, Rambaldi ML, de Andrade FC, Kelmer Sde C, Barbosa FC (2012) The therapeutic benefit of allopurinol in the treatment of foreign body granulomas caused by polymethylmethacrylate microspheres. Case Rep Dermatol Med 2012:945205PubMedPubMedCentral
60.
go back to reference Tsai TF, Yeh TY (2010) Allopurinol in dermatology. Am J Clin Dermatol 11(4):225–232PubMed Tsai TF, Yeh TY (2010) Allopurinol in dermatology. Am J Clin Dermatol 11(4):225–232PubMed
61.
go back to reference Badgwell C, Rosen T (2007) Cutaneous sarcoidosis therapy updated. J Am Acad Dermatol 56(1):69–83PubMed Badgwell C, Rosen T (2007) Cutaneous sarcoidosis therapy updated. J Am Acad Dermatol 56(1):69–83PubMed
62.
go back to reference Breghoej A, Jemec GB (2005) Low-dose allopurinol in the treatment of cutaneous sarcoidosis: response in four of seven patients. J Dermatol Treat 16:125–127 Breghoej A, Jemec GB (2005) Low-dose allopurinol in the treatment of cutaneous sarcoidosis: response in four of seven patients. J Dermatol Treat 16:125–127
63.
go back to reference El-Euch D, Mokni M, Trojjet S, Khouaja A, Osman AB (1999) Sarcoidosis in a child treated successfully with allopurinol. Br J Dermatol 140:1184–1185PubMed El-Euch D, Mokni M, Trojjet S, Khouaja A, Osman AB (1999) Sarcoidosis in a child treated successfully with allopurinol. Br J Dermatol 140:1184–1185PubMed
64.
go back to reference Pfau A, Stolz W, Karrer S, Szeimies RM, Landthaler M (1998) Allopurinol in treatment of cutaneous sarcoidosis. Hautarzt 49:216–218PubMed Pfau A, Stolz W, Karrer S, Szeimies RM, Landthaler M (1998) Allopurinol in treatment of cutaneous sarcoidosis. Hautarzt 49:216–218PubMed
65.
go back to reference Nakahara T, Morimoto H, Murakami N, Furue M (2018) Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. Pediatr Allergy Immunol 29(3):233–238PubMed Nakahara T, Morimoto H, Murakami N, Furue M (2018) Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. Pediatr Allergy Immunol 29(3):233–238PubMed
66.
go back to reference Cury Martins J, Martins C, Aoki V, Gois AF, Ishii HA, da Silva EM (2015) Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev 7:CD009864 Cury Martins J, Martins C, Aoki V, Gois AF, Ishii HA, da Silva EM (2015) Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev 7:CD009864
67.
go back to reference Caproni M, Torchia D, Antiga E et al (2007) The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. Br J Dermatol 156:312–319PubMed Caproni M, Torchia D, Antiga E et al (2007) The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. Br J Dermatol 156:312–319PubMed
68.
go back to reference Amin AR, Patel RN, Thakker GD, Lowenstein CJ, Attur MG, Abramson SB (1997) Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett 410:259–264PubMed Amin AR, Patel RN, Thakker GD, Lowenstein CJ, Attur MG, Abramson SB (1997) Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett 410:259–264PubMed
69.
go back to reference Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR (1991) Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2:297–321PubMed Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR (1991) Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2:297–321PubMed
70.
71.
go back to reference Humbert P, Treffel P, Chapuis JF, Buchet S, Derancourt C, Agache P (1991) The tetracyclines in dermatology. J Am Acad Dermatol 25:691–697PubMed Humbert P, Treffel P, Chapuis JF, Buchet S, Derancourt C, Agache P (1991) The tetracyclines in dermatology. J Am Acad Dermatol 25:691–697PubMed
72.
go back to reference Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258–265PubMed Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258–265PubMed
73.
go back to reference Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137:69–73PubMed Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137:69–73PubMed
74.
go back to reference Korting HC, Schöllmann C (2009) Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol 23:876–882PubMed Korting HC, Schöllmann C (2009) Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol 23:876–882PubMed
75.
go back to reference Marcoval J, Mana J, Moreno A et al (2001) Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol 137:427–430PubMed Marcoval J, Mana J, Moreno A et al (2001) Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol 137:427–430PubMed
76.
go back to reference Hurst EA, Mauro T (2005) Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 141:865–868PubMed Hurst EA, Mauro T (2005) Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 141:865–868PubMed
77.
go back to reference Mayberry J, Lee WM (2019) The revolution in treatment of hepatitis C. Med Clin N Am 103(1):43–55PubMed Mayberry J, Lee WM (2019) The revolution in treatment of hepatitis C. Med Clin N Am 103(1):43–55PubMed
78.
go back to reference Tivol EA, Borriello F, Schweitzer AN et al (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3(5):541–547PubMed Tivol EA, Borriello F, Schweitzer AN et al (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3(5):541–547PubMed
79.
80.
go back to reference Ning F, Liu H, Lash GE (2016) The role of decidual macrophages during normal and pathological pregnancy. Am J Reprod Immunol 75(3):298–309PubMed Ning F, Liu H, Lash GE (2016) The role of decidual macrophages during normal and pathological pregnancy. Am J Reprod Immunol 75(3):298–309PubMed
Metadata
Title
PMMA Safety for Facial Filling: Review of Rates of Granuloma Occurrence and Treatment Methods
Author
Bruno Peres Paulucci
Publication date
01-02-2020
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 1/2020
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-019-01522-2

Other articles of this Issue 1/2020

Aesthetic Plastic Surgery 1/2020 Go to the issue